You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

Dr. Reddy's to Conduct Human Trial for Sputnik V COVID-19 Vaccine in India, an Industrial Info Market Brief

default

Industry Segment: Market Brief | Word Count: 148 Words
Attachment: DrReddy 1020

Indian pharmaceutical major Dr. Reddy's Laboratories Limited is set to begin human clinical trials in India for the Sputnik V vaccine, which is being developed by the Gamaleya National Research Institute of Epidemiology & Microbiology in Russia.

Subscribe Now! All Fields Required...

Standard Membership - Free